Skip to main content


Media Coverage

Rejecting Brand-Liability Theory Post-Mensing

19 December 2011
Bylined article by New York Litigation partner Henninger Bullock and associate Andrew Calica discusses the ruling in Smith v. Wyeth Inc. that brand manufacturers of Reglan could not be held liable for injuries caused by their competitors’ generic versions of the drug.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.